Literature DB >> 15032391

Radial nerve palsy owing to localized hypertrophic neuropathy (intraneural perineurioma) in early childhood.

Sherif Isaac1, Nicholas A Athanasou, Michael Pike, Peter D Burge.   

Abstract

Localized hypertrophic neuropathy, also termed intraneural perineurioma, is a rare disorder of unknown etiology that produces a slowly progressive painless focal lesion of a peripheral nerve. It is characterized histologically by concentric whorls ("onion bulbs") of epithelial membrane antigen-reactive, S-100 protein-negative perineurial cells surrounding nerve fibers. We report a radial nerve palsy in a child aged 2 years in whom the diagnosis of localized hypertrophic neuropathy was made by biopsy. Resection of the affected nerve segment and sural nerve grafting produced no useful recovery after 3 years, probably because of the long duration of denervation. When this mononeuropathy presents in early childhood, uncertainty over the time of onset can lead to difficulty in distinguishing this potentially treatable lesion from congenital and other causes of nerve palsy.

Entities:  

Mesh:

Year:  2004        PMID: 15032391     DOI: 10.1177/08830738040190010711

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  3 in total

1.  Longitudinal study of intraneural perineurioma--a benign, focal hypertrophic neuropathy of youth.

Authors:  Michelle L Mauermann; Kimberly K Amrami; Nancy L Kuntz; Robert J Spinner; Peter J Dyck; E Peter Bosch; Janean Engelstad; Joel P Felmlee; P James B Dyck
Journal:  Brain       Date:  2009-06-30       Impact factor: 13.501

Review 2.  Intraneural perineurioma affecting multiple nerves: a case report and literature review.

Authors:  Lei-Ming Wang; Yan-Feng Zhong; Dan-Feng Zheng; A-Ping Sun; Ying-Shuang Zhang; Rong-Fang Dong; Yi Pan
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

3.  Modern treatment of perineuriomas: a case-series and systematic review.

Authors:  Anne-Kathrin Uerschels; Christos Krogias; Andreas Junker; Ulrich Sure; Karsten H Wrede; Oliver Gembruch
Journal:  BMC Neurol       Date:  2020-02-13       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.